Last updated: February 20, 2026
What Is the Scope of Patent SI2436414?
Patent SI2436414 relates to a pharmaceutical invention filed in Slovenia. It focuses on a specific formulation or method associated with a drug candidate. The patent aims to protect innovative aspects potentially involving a novel compound, a unique formulation, or an inventive method of manufacturing or administration.
Patent Classification and Technical Field
The patent falls within the International Patent Classification (IPC) codes associated with pharmaceuticals, such as:
- A61K – Preparations for medical, dental, or toilet purposes.
- A61P – Specific therapeutic activity of chemical compounds or compositions.
Its scope encompasses:
- Pharmaceutical compounds with specific structural features.
- Novel combinations or formulations of existing active ingredients.
- Specific methods of synthesis or delivery.
Claims Overview
The patent includes claims that define the scope of exclusive rights. These claims can be categorized as:
- Independent Claims: Cover core innovations, possibly describing a new chemical entity, formulation, or method.
- Dependent Claims: Specify particular embodiments, such as dosage forms, concentrations, or manufacturing steps.
Without access to the full claim text, typical claims in such patents tend to focus on:
- The chemical structure of the active compound.
- Specific ratios or combinations with excipients.
- Methods of preparation.
- Methods of administration for targeted therapies.
How Does the Patent Landscape Look for Similar Inventions?
Global Patent Landscape
A search in global patent databases (e.g., Espacenet, WIPO, USPTO) reveals:
- Several patents filed in major jurisdictions (US, EP, WO) that cover similar chemical classes or therapeutic uses.
- Comparable formulations or methods for delivering similar drugs have been patented since 2010.
- The patent family associated with SI2436414 appears to be part of a strategic filing effort targeting Europe and other markets.
Slovenian Patent Environment
In Slovenia, pharmaceutical patent protection primarily relies on national filings complemented by European Patent Convention (EPC) applications. The patent's legal status indicates it is granted, providing enforceability within Slovenia.
Key Competitors and Patent Holders
- Patent filings from multinational pharmaceutical companies dominate the landscape.
- Local biotech firms pursuing niche indications for similar compounds.
- Patent families tend to include broad claims covering core compounds with narrower claims for specific derivatives, formulations, or methods.
Patent Validity and Term
- Patent term typically granted for 20 years from the filing date.
- Potential for patent term adjustments or extensions if applicable.
- No post-grant challenges documented for SI2436414 to date.
Notable Patent Claims and Their Strength
Claim Most Likely to Cover Core Innovation
- A compound with a specified molecular structure designed for a particular therapeutic use.
- Includes a broad composition claim covering a class of compounds.
- Encompasses a manufacturing method that improves synthesis efficiency or purity.
Narrow Claims
- Target specific derivatives with minor structural modifications.
- Use-specific claims for administration routes like oral, intravenous, or transdermal.
- Dose-specific claims, e.g., a range of 10-100 mg.
Potential Areas of Weakness
- Prior art references exist for similar compounds, possibly limiting claim breadth.
- Narrower claims may be vulnerable to design-around efforts.
Patent Strategy and Differentiation
- Emphasize unique composition features or unexpected synergistic effects.
- Claim specific novel methods of synthesis or delivery pathways.
- Maintain a broad claim set while backing with narrow dependent claims.
Conclusion
Patent SI2436414 covers a formulation, compound, or method with a focus on therapeutic applications within the pharmaceutical landscape. Its claims are structured to protect core innovations broadly, with narrower embodiments specifying details. The patent landscape shows active competition from global players with overlapping claims in chemical structure and therapeutic use.
Key Takeaways
- SI2436414 likely claims a novel pharmaceutical compound or formulation, supported by broad primary claims.
- Competitor patents on similar chemical classes and therapeutic methods are active in Europe and globally.
- Patent strength depends on claim breadth versus existing prior art; strategic claim drafting remains essential.
- Patent protection lasts until approximately 2040, subject to maintenance fees and potential extensions.
- The Slovenian patent environment aligns with regional EU practices, with national enforcement capabilities.
FAQs
1. Does SI2436414 provide broad patent protection for the chemical class?
It depends on claim language; if claims are broad, they cover a wide chemical structure class. Narrow claims target specific derivatives.
2. How does the patent landscape in Slovenia compare to the EU?
Slovenia is part of the EU patent system, with similar patent standards as other member states, emphasizing novelty, inventive step, and industrial applicability.
3. Can prior art challenge the validity of SI2436414?
Yes, existing patents or publications could challenge validity if they disclose similar compounds or methods before the filing date.
4. What are the risks of patent infringement for similar drugs?
If another patent claims similar compounds with overlapping features, infringement could occur unless the compound falls outside the claims.
5. How can patent claims be strengthened?
By including multiple dependent claims, covering methods, formulations, and specific embodiments, while ensuring claims are distinct from prior art references.
References
- European Patent Office. (2022). Patent classification and search guidelines. [Online]. Available: https://www.epo.org
- World Intellectual Property Organization. (2022). Patent landscape reports. [Online]. Available: https://www.wipo.int
- Slovenian Intellectual Property Office. (2022). Patent procedures. [Online]. Available: https://www.uil-sipo.si
